Enriched cancer pathway | Genes under regulation | P value |
Natural killer cell mediated cytotoxicity |
4 genes: NFAT5, FCGR3A, FCGR3B, PIK3R1
|
0.006563 |
VEGF signaling pathway |
3 genes: NFAT5, PIK3R1, PLA2G4A
|
0.008297 |
Phosphatidylinositol signaling system |
3 genes: INPP5A, PIK3R1, SYNJ2
|
0.008909 |
Wnt signaling pathway |
4 genes: NFAT5, CREBBP, SFRP1, SKP1
|
0.009417 |
Fc gamma R.mediated phagocytosis |
3 genes: FCGR3A, PIK3R1, PLA2G4A
|
0.01517 |
Cell cycle |
3 genes: CREBBP, RB1, SKP1
|
0.03291 |
Osteoclast differentiation |
3 genes: FCGR3A, FCGR3B, PIK3R1
|
0.03291 |
Inositol phosphate metabolism |
2 genes: INPP5A, SYNJ2
|
0.03868 |
Arachidonic acid metabolism |
2 genes: PLA2G4A, PTGS1
|
0.04118 |